Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
62
天
Pharmacokinetics, Safety, and Immunogenicity of DMB-3115, a Ustekinumab Biosimilar for Immune-Mediated Diseases, in Healthy Japanese Male Participants: A Randomized, Double-Blind, Single-Dose Study
作者
Hironori Konishi; Takeyuki Shindo; Michio Yagi; Takashi Eto; Rie Yazawa; Makoto Yono; Naoki Cho; Hideki Fushimi; Jun Morita展开收起
作者单位
1. R and D Division, Meiji Seika Pharma Co., Ltd., Tokyo, Japan; 2. Medical Corporation Heishinkai OPHAC Hospital, Osaka, Japan; 3. Souseikai Hakata Clinic, Fukuoka, Japan; 4. Souseikai Sumida Hospital, Tokyo, Japan; 5. Souseikai Nishikumamoto Hospital, Kumamoto, Japan展开收起
112
天
Costs of Comorbidities and Complications Associated with Type 2 Diabetes: A Retrospective, Cohort Study
作者
Kendra A. Terrell; Maureen J. Lage; William J. Valentine; Jim S. Paik; Kristina S. Boye展开收起
作者单位
1. Eli Lilly and Company, Lilly Corporate Center, Indianapolis, USA; 2. HealthMetrics Outcomes Research, Branford, USA; 3. Ossian Health Economics and Communications, Basel, Switzerland展开收起
56
天
An Examination into the Anti-stress and Anti-fatigue Effects of an Ashwagandha Extract (Ashwa.30™) in Stressed Adults: A Randomised, Double-Blind, Placebo-controlled Trial
作者
Adrian L. Lopresti; Stephen J. Smith; Bharathi Bethapudi; Auxi Arobana R; Deepak Mundkinajeddu; Prashanth D’Souza; Suresh Lakshmikanthan展开收起
作者单位
1. Clinical Research Australia, Duncraig, Perth, Australia; 2. College of Science, Health, Engineering and Education, Murdoch University, Perth, Australia; 3. Natural Remedies Pvt Ltd, Bengaluru, India展开收起
180
天
Humanistic Burden and Gaps in Care and Treatment Policies of Obesity in Canada: A Systematic Review
作者
Christine Longuet; Esther Artime; Jennifer Glass; Sam Riley; Rachel Kewley; Jennifer L. Kuk; Ian Patton; David C. W. Lau展开收起
作者单位
1. Eli Lilly and Company, Toronto, Canada; 2. Eli Lilly and Company, Madrid, Spain; 3. Formerly Adelphi Values PROVE, Bollington, UK; 4. School of Kinesiology and Health Science, York University, Toronto, Canada; 5. Obesity Canada – Obesité Canada, 2-126 Li Ka Shing Centre for Health Research Innovation, University of Alberta, Edmonton, Canada; 6. Department of Medicine, University of Calgary Cumming School of Medicine, Calgary, Canada展开收起
35
天
Real-World Adult Height Outcomes in Girls with Central Precocious Puberty Receiving GnRHa Monotherapy or Combined with Growth Hormone: A Cohort Study in China
作者
Fei Wang; Yan Li; Yu Yang; Wei Gu; Xuan Xu; Haiying Wu; Guimei Li; Xiaoqin Yin; Shasha Zhou; Pin Li展开收起
作者单位
1. Department of Endocrinology, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; 2. Department of Endocrinology, Genetics and Metabolism, Jiangxi Provincial Children’s Hospital, Nanchang, China; 3. Department of Endocrinology, Genetics and Metabolism, Children’s Hospital of Nanjing Medical University, Nanjing, China; 4. Department of Pediatric Endocrinology, Hunan Provincial People’s Hospital, Changsha, China; 5. Department of Endocrinology, Genetics and Metabolism, Children’s Hospital of Soochow University, Suzhou, China; 6. Department of Pediatrics, Shandong Provincial Hospital, Jinan, China展开收起
45
天
Sacral Neuromodulation for Refractory Overactive Bladder: Closing the Gaps in Anatomy, Mechanisms, and Parameter Selection
作者
Daniel P. Marshall; Isha Chugh; Cindy L. Amundsen; Nazema Y. Siddiqui; Warren M. Grill展开收起
作者单位
1. Department of Biomedical Engineering, Duke University, Durham, USA; 2. Department of Electrical and Computer Engineering, Duke University, Durham, USA; 3. Department of Obstetrics and Gynecology, Urogynecology, Duke University, Durham, USA; 4. Department of Urology, Duke University, Durham, USA; 5. Department of Neurobiology, Duke University, Durham, USA; 6. Department of Neurosurgery, Duke University, Durham, USA展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天